Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$111M |
| 2 |
Ferguson
FERG
|
+$106M |
| 3 |
Apple
AAPL
|
+$103M |
| 4 |
Amazon
AMZN
|
+$103M |
| 5 |
Tesla
TSLA
|
+$75.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TIF
Tiffany & Co.
TIF
|
+$96.7M |
| 2 |
DuPont de Nemours
DD
|
+$51.9M |
| 3 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$43.4M |
| 4 |
AvalonBay Communities
AVB
|
+$36.1M |
| 5 |
Equity Residential
EQR
|
+$21.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.7% |
| 2 | Healthcare | 14.14% |
| 3 | Consumer Discretionary | 13.71% |
| 4 | Communication Services | 10.92% |
| 5 | Industrials | 9.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
ImmunityBio
IBRX
$8.11B
| $1.77M | ﹤0.01% |
74,500
+1,300
| +2% | +$33.7K |
|
2077
Progyny
PGNY
$1.99B
| $1.76M | ﹤0.01% |
39,600
+1,000
| +3% | +$46.7K |
|
2078
Alaunos Therapeutics
TCRT
$4.86M
| $1.76M | ﹤0.01% |
3,264
+27
| +0.8% | +$16.8K |
|
|
TPC
2079
Tutor Perini Cor
TPC
$4.98B
| $1.76M | ﹤0.01% |
92,900
+1,200
| +1% | +$20.3K |
|
2080
Harmonic Inc
HLIT
$1.42B
| $1.75M | ﹤0.01% |
223,315
+4,400
| +2% | +$34.8K |
|
|
SRDX
2081
DELISTED
Surmodics
SRDX
| $1.75M | ﹤0.01% |
31,200
+700
| +2% | +$34.9K |
|
|
RC
2082
Ready Capital
RC
$294M
| $1.75M | ﹤0.01% |
130,045
+37,000
| +40% | +$480K |
|
|
OSG
2083
Octave Specialty Group
OSG
$212M
| $1.74M | ﹤0.01% |
103,800
| – | – |
|
2084
Construction Partners
ROAD
$6.73B
| $1.74M | ﹤0.01% |
58,100
+700
| +1% | +$21.1K |
|
|
TVTY
2085
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $1.74M | ﹤0.01% |
77,775
+900
| +1% | +$20.6K |
|
2086
Universal Electronics
UEIC
$66.6M
| $1.73M | ﹤0.01% |
31,524
| – | – |
|
|
PETQ
2087
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $1.73M | ﹤0.01% |
49,100
+1,200
| +3% | +$42.5K |
|
2088
Nicolet Bankshares
NIC
$3.73B
| $1.73M | ﹤0.01% |
20,700
-600
| -3% | -$45.7K |
|
|
MAGN
2089
Magnera Corp
MAGN
$433M
| $1.72M | ﹤0.01% |
7,723
| – | – |
|
|
NFBK
2090
DELISTED
Northfield Bancorp
NFBK
| $1.72M | ﹤0.01% |
108,100
| – | – |
|
2091
Scansource
SCSC
$1.06B
| $1.72M | ﹤0.01% |
57,400
| – | – |
|
2092
Sportsman's Warehouse
SPWH
$46.8M
| $1.72M | ﹤0.01% |
99,700
+1,100
| +1% | +$19.1K |
|
2093
Kelly Services Class A
KELYA
$566M
| $1.72M | ﹤0.01% |
77,100
| – | – |
|
2094
Turning Point Brands
TPB
$1.73B
| $1.72M | ﹤0.01% |
32,900
+6,600
| +25% | +$329K |
|
2095
Camtek
CAMT
$8.06B
| $1.71M | ﹤0.01% |
59,472
+5,967
| +11% | +$160K |
|
2096
Central Pacific Financial
CPF
$1B
| $1.71M | ﹤0.01% |
64,200
| – | – |
|
2097
AdvanSix
ASIX
$446M
| $1.71M | ﹤0.01% |
63,700
| – | – |
|
|
MYOV
2098
DELISTED
Myovant Sciences Ltd.
MYOV
| $1.7M | ﹤0.01% |
82,800
+1,300
| +2% | +$29.6K |
|
|
XRN
2099
Chiron Real Estate Inc
XRN
$484M
| $1.7M | ﹤0.01% |
25,920
+6,060
| +31% | +$403K |
|
|
ESPR
2100
DELISTED
Esperion Therapeutics
ESPR
| $1.7M | ﹤0.01% |
60,500
+1,000
| +2% | +$29.5K |
|
Similar funds
Swiss National Bank's Q1 2021 Portfolio in Review
As of Q1 2021, Swiss National Bank held 2,502 positions worth $150B, up 6.6% from $141B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q1 2021: portfolio turnover was 1.3%. Swiss National Bank opened 12 new positions and exited 20, leaving the 2,502-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q1 2021 buy was Ferguson: 872,392 shares worth $104M.
- Swiss National Bank added most to Microsoft in Q1 2021, an estimated $111M increase.
- Swiss National Bank's biggest Q1 2021 reduction was DuPont de Nemours, cutting an estimated $51.9M.
- Swiss National Bank fully exited Tiffany & Co. in Q1 2021, selling an estimated $96.7M.
- Swiss National Bank's ten largest holdings make up 23% of its $150B portfolio in Q1 2021.
- Swiss National Bank opened 12 new positions and closed 20 in Q1 2021.
- Swiss National Bank's portfolio value rose 6.6% quarter-over-quarter to $150B.
Based on Swiss National Bank's 13F filing for Q1 2021, filed 7 May 2021.